Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment

Inclusion Criteria:

- Age 16 or over.

- Have documentation of physician-confirmed diagnosis of moderate or severe Hemophilia A
(severity defined as moderate = FVIII activity 1% to 5% and severe = FVIII activity
≤1%).

- Signed written informed consent provided by the patient or the patient's parents for
patients under the age of 18 (dependent of local regulations).

- Signed written assent is also required for patients under the age 18 years (dependent
on local regulations).

- Plan to receive at least half of their Hemophilia care at the registry site.

- Willing and able to enter data as per the data collection schedule.

- Currently receiving prophylactic or on demand treatment (including within last 6months
for on demand).

- Expected life expectancy of at least 2 years.

Exclusion Criteria:

- Patients with Hemophilia B

- Patients with von Willebrand disease (vWD)

- Patients with other rare bleeding disorders

- Unable to comply with the study protocol